Full-Time

Manager – Phase II/III Research

Full Time, Wolf River

Updated on 9/4/2026

West Cancer Center

West Cancer Center

51-200 employees

Provides cancer care with clinical trials

No salary listed

Germantown, TN, USA

In Person

Bachelor's

Category
Biology & Biotech (1)

Get referred to West Cancer Center

See people who can refer or advise you

Requirements
  • A bachelor's degree from an accredited four-year college or university with a minimum of three years of related experience; or five to seven years of related experience and/or training in a healthcare or clinical research environment; or an equivalent combination of education and experience.
  • Excellent organizational and follow-up skills.
  • Excellent verbal and written communication skills.
  • Strong problem-solving skills with the ability to organize and prioritize work assignments.
  • Ability to manage multiple priorities in a fast-paced environment.
  • Ability to analyze situations and respond in a timely manner.
  • Ability to work effectively within multidisciplinary teams.
  • Ability to establish and maintain effective working relationships throughout West Cancer Center.
  • Proficiency in computer applications, including word processing and email.
  • Ability to read, analyze, and interpret financial reports, government regulations, scientific journals, technical documents, and legal documents.
  • Ability to communicate effectively both verbally and in writing with customers, regulatory agencies, and members of the business community.
  • Ability to effectively present information to leadership, employee groups, and public audiences.
  • Ability to calculate figures and amounts, including discounts, percentages, body surface area, absolute neutrophil count, drug calculations, area, circumference, and volume.
  • Ability to apply concepts of basic algebra and geometry.
  • Ability to define problems, collect data, establish facts, and draw valid conclusions.
  • Ability to interpret complex technical instructions and manage multiple abstract and concrete variables.
  • Additional hours may be required.
  • Travel may be required.
  • Ability to work near toxic or caustic chemicals.
  • Ability to sit, stand, walk, reach, climb or balance, stoop or crouch, and use hands and wrists for extended periods of time.
  • Ability to lift up to 10 pounds.
Responsibilities
  • Supervise Clinical Research Coordinators within the Phase II/III research program and oversee daily clinical trial activities.
  • Educate new Phase II/III clinical team members on research processes and WCCRI policies and procedures.
  • Assign projects and monitor team workloads to ensure efficient study execution.
  • Recruit subjects for clinical trials using a variety of recruitment methods.
  • Screen potential subjects for eligibility by reviewing medical history and current clinical findings.
  • Educate nursing staff regarding protocol therapy administration and expected side effects.
  • Educate patients on protocol therapies, medication schedules, expected side effects, and appropriate actions to take if side effects occur.
  • Provide education to clinic staff regarding clinical trial opportunities and protocol requirements.
  • Assist with audit preparation and facilitate sponsor and academic partner audits.
  • Protect the rights, safety, and welfare of research participants.
  • Obtain and maintain informed consent documentation throughout each study.
  • Review newly activated protocols, protocol amendments, notices, suspensions, and study terminations.
  • Maintain current knowledge of the Code of Federal Regulations.
  • Collaborate with physicians, physician nurses, chemotherapy nurses, radiology, medical records, scheduling, phlebotomy, laboratory, insurance, and pharmacy regarding research activities.
  • Manage relationships with academic partners to develop and maintain the research portfolio.
  • Collaborate with physician investigators and academic partners to develop study protocols, informed consent documents, electronic case report forms, and data capture portals.
  • Coordinate with research team members to develop study budgets and facilitate contractual agreements for academic projects.
  • Maintain professionalism while respecting the dignity and confidentiality of patients.
  • Comply with clinic safety policies and procedures.
  • Attend staff meetings and participate in team-oriented collaboration.
  • Interface internally with Site Data Services, Regulatory Affairs, and Contracts/Budgeting personnel.
  • Interface externally with research sites, sponsors, and Contract Research Organizations.
  • Perform all other duties as assigned.
Desired Qualifications
  • Clinical research certification through the Society of Clinical Research Associates or the Association of Clinical Research Professionals.

West Cancer Center provides comprehensive cancer care with access to Phase I–III clinical trials through a partnership with Methodist Healthcare and the University of Tennessee Health Science Center. Patients receive standard cancer care and may enroll in trials, while clinicians and researchers collaborate across the lab and clinic to develop and apply new therapies. This collaboration gives patients early trial access and a lab-to-clinic workflow that ties research directly to treatment. The goal is to improve cancer outcomes by speeding up research and turning findings into effective, evidence-based therapies for patients.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Brighton, Colorado

Founded

1979

Get referred to West Cancer Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • May 4, 2026 Bartlett opening expands surgical access and should drive new patient volume.
  • April 2026 Atlas launch embeds value-based care teams beside West's oncologists.
  • West's trial pipeline and 2026 conference reinforce recruiting, research prestige, and physician loyalty.

What critics are saying

  • 2022 DOJ case against Methodist ties West to anti-kickback allegations and reputational spillover.
  • West still depends on Methodist and UTHSC partnerships for referrals, trials, and credibility.
  • A concentrated Memphis footprint leaves West vulnerable if local competitors capture oncology growth.

What makes West Cancer Center unique

  • West Cancer Center operates 11 campuses across Memphis and West Tennessee.
  • April 7, 2026 partnerships with IDEOlogy Health deepen provider education and clinical integration.
  • July 28, 2026 ChoICE trial made West the first U.S. ProSense cryoablation site.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

West Cancer Center
Jul 28th, 2026
Advancing breast cancer care with cryoablation therapy.

Advancing breast cancer care with cryoablation therapy. Jul 28th, 2026 West Cancer Center is so proud to announce the launch of a groundbreaking clinical study with IceCure Medical, making its network the 1st U.S. clinical site for the company's ProSense(R) cryoablation technology. The ChoICE Study will evaluate the use of ProSense(R) cryoablation in low-risk breast cancer patients, enrolling approximately 400 patients across 30 clinical sites nationwide. This important research will help gather real-world data and advance the use of innovative, minimally invasive treatment options for eligible patients. This technology, which has received FDA approval for use in patients age 70 and older with low-risk breast cancer, offers a potential alternative to traditional surgical treatment by using a minimally invasive approach designed with patient experience in mind. The study within its network will be led by Dr. Richard Gilmore, breast surgical oncologist, whose expertise and leadership will help advance research focused on improving breast cancer treatment options. At West, West Cancer Center remain committed to bringing innovative therapies and clinical research opportunities to its patients while continuing to redefine what is possible in cancer care.

Memphis Medical News
May 4th, 2026
West Cancer Center news briefs.

West Cancer Center news briefs. May 04, 2026 at 02:55 pm by pjeter West Cancer Center & Research Institute is pleased to announce that Dr. Allison Vaughn Jones has joined their Dermatology Multidisciplinary Clinic. Jones is a highly respected, board certified dermatologist at UT Dermatology and brings extensive experience in diagnosing and managing complex skin conditions, including those that intersect with oncology care. She will be collaborating with Dr. Jason Chandler and Dr. David Portnoy to enhance coordinated care for patients with skin cancers, treatment related dermatologic concerns, and other conditions that benefit from integrated expertise. This is a collaboration between West Cancer Center and Research Institute and the University of Tennessee Health Science Center. Jones will continue her practice at UT as the Assistant Professor of Dermatology at UTHSC, while collaborating with Dr. Portnoy. West Cancer Center & Research Institute has opened a new clinic location in Bartlett. This expansion reflects their continued commitment to increasing access to high-quality cancer care across the Mid-South. The Bartlett office will operate Monday through Thursday and will initially function as a surgery clinic. The following specialists will be providing services at the Bartlett location. Head & Neck Oncology - Dr. Richard Muller Breast Surgical Oncology - Dr. Linda Han Gynecologic Oncology - Dr. Todd Tillmanns Urogynecology - Dr. Ben Abdu Dr. Axel Grothey, medical oncologist and Director of Gastrointestinal Cancer Research at West Cancer Center & Research Institute, recently authored a powerful column in The Tennessean highlighting the urgent need for colorectal cancer screening across Tennessee. Grothey sheds light on the state's high rates of colon cancer diagnoses and deaths, while emphasizing that early detection can dramatically improve outcomes. His column also introduces a promising new FDA-approved blood test - the Shield test - which offers a more convenient, non-invasive screening option for eligible adults. Through his perspective, Grothey reinforces a critical message: one conversation with a doctor and one screening test can truly save lives. A new study published in Nature Publishing Group highlights promising strategies to improve adherence to oral endocrine therapy (AET) among younger breast cancer patients - an area critical to long-term outcomes. Dr. Gregory Vidal co-authored this important research, which examined the impact of app-based remote monitoring on treatment adherence. Findings from this randomized trial demonstrated that premenopausal women using a remote symptom-monitoring app achieved significantly higher 12-month adherence rates compared to usual care (53.9 percent vs. 25.0 percent), while no significant benefit was observed among postmenopausal patients. These results underscore the unique challenges younger patients face and highlight remote monitoring as a scalable, technology-driven approach to help close adherence gaps and improve outcomes. Link: https://www.nature.com/articles/s41523-026-00900-9

The Tifton Gazette
Apr 7th, 2026
West Cancer Center and IDEOlogy Health announce strategic partnership to advance patient-centered oncology education and care.

West Cancer Center and IDEOlogy Health announce strategic partnership to advance patient-centered oncology education and care. PR Newswire Today at 7:42am PDT MEMPHIS, Tenn. and AUSTIN, Texas, April 7, 2026 /PRNewswire/ - West Cancer Center & Research Institute, the Mid-South's premier provider of comprehensive adult cancer care, and IDEOlogy Health, a leader in delivering non-promotional, multi-channel medical education to oncology professionals, today announced two exclusive strategic partnership agreements designed to elevate physician and Advanced Practice Provider (APP) education. Together, these collaborations aim to strengthen oncology care delivery and improve outcomes for patients across the community. With more than 46 years of oncology expertise, 113 specialized providers, and care provided to more than 68,000 patients annually, West Cancer Center & Research Institute is a nationally recognized model for integrated cancer care. West offers advanced treatments, innovative therapies, and comprehensive patient support services, all grounded in research-driven and compassionate care. IDEOlogy Health is widely recognized for its commitment to "Creating Aha! Moments in Healthcare(R)" and for leading innovation in how healthcare professionals stay current with advancements in medicine. Through expert-led programs, roundtable discussions, and real-time clinical data updates, IDEOlogy Health empowers oncology providers with timely, relevant insights that can impact patient care from day one. A Shared Commitment to Patients This partnership reflects a shared vision between West Cancer Center & Research Institute and IDEOlogy Health: to enhance the patient journey by equipping oncology care teams with high-quality clinical education and practical tools that support exceptional, holistic care. "Our partnership with IDEOlogy Health reflects West Cancer Center & Research Institute's continued commitment to leading the region in advanced, evidence-based oncology care," said Sylvia Richey, MD, Medical Oncologist and Chief Medical Officer for West. "By expanding access to the latest clinical insights and high-quality educational resources, we are strengthening the expertise of our physicians and advanced practice providers. This collaboration further enhances our ability to deliver exceptional, patient centered care across every community we serve." By combining IDEOlogy Health's innovative educational platforms with West's deep clinical expertise, the collaboration will help accelerate the integration of emerging research into everyday clinical practice, ensuring patients benefit from the latest scientific advancements, regardless of where they receive care. "We're thrilled to partner with West Cancer Center to deliver a multi-channel medical education program tailored to the needs of its physicians and advanced practice providers," said Cameron Lush, President of IDEOlogy Health. "This partnership helps ensure care teams have timely access to the latest clinical insights to support the best possible outcomes for patients." About West Cancer Center & Research Institute West Cancer Center & Research Institute is a nationally recognized leader in adult cancer care, offering comprehensive oncology services across multiple locations in the Mid-South. With a mission rooted in research, advanced treatments, prevention, and equitable access to care, West's multidisciplinary team delivers exceptional support to patients and families throughout the entire cancer journey. About IDEOlogy Health IDEOlogy Health, part of The Lockwood Group, is leading the change in how healthcare professionals connect and stay up to date on the latest advancements in medicine. The company leverages decades of healthcare expertise and emerging technology to provide data, analysis, and educational opportunities from experts across the globe in therapeutic areas of Oncology and Hematology. SOURCE IDEOlogy Health This is a paid placement. For further inquiries, please contact PR Newswire directly.

Associated Press
Jan 21st, 2026
Atlas Oncology Partners launches in Memphis to improve cancer care through value-based model

Atlas Oncology Partners, a value-based cancer care company, has officially launched in Memphis, Tennessee, with its first partner, West Cancer Center & Research Institute. The company aims to enhance existing cancer care by embedding support teams within partner practices to guide patients through all phases of treatment. Atlas offers whole-person care coordination, psychosocial support, and management of cancer-adjacent conditions. The company's model includes onsite and virtual care teams working alongside oncologists whilst assuming full medical cost risk. Founded by President Kate Roberts and Chief Medical Officer Dr Gabrielle Rocque, Atlas plans to expand throughout the Southeast in 2026, targeting markets in Alabama, Arkansas, Louisiana, Mississippi and Texas. The company remains in pre-revenue stage whilst establishing its partnership model.

Memphis Magazine
Jun 4th, 2024
Top Doctor: Dr. Sonia Benn

The oncologist with West Cancer Center has been named one of the 2024 Top Doctors in Memphis by the Castle Connolly research group.